The word kratom now gets used for products that can differ dramatically: traditional leaf material, powders, conventional extracts, branded shots, isolated alkaloids, and concentrated 7-hydroxymitragynine tablets or gummies.
The point of this page is not to declare every leaf product harmless. It is to prevent a different error: treating a low-concentration botanical product and a deliberately concentrated opioid-active product as though they are the same consumer experience.
Questions to ask when reading a label
- Does the label state total alkaloids and 7-OH content clearly?
- Is “serving” being used in a way that hides how much product is in one tablet, shot, or package?
- Does the product make medical claims without approved-drug evidence?
- Is the product presented as ordinary kratom while emphasizing isolated or enhanced alkaloids?
FDA stated in July 2025 that its proposed scheduling action focused on concentrated 7-OH products rather than natural kratom leaf products. Because regulation changes, readers should verify current federal and state law rather than relying on old search snippets.